Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4786585
Max Phase: Preclinical
Molecular Formula: C45H55N11O10
Molecular Weight: 910.00
Molecule Type: Unknown
Associated Items:
ID: ALA4786585
Max Phase: Preclinical
Molecular Formula: C45H55N11O10
Molecular Weight: 910.00
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(N)=O
Standard InChI: InChI=1S/C45H55N11O10/c46-16-6-5-11-33(42(63)55-35(17-24-12-14-27(57)15-13-24)43(64)53-34(40(49)61)21-39(59)60)52-44(65)37(19-26-23-51-32-10-4-2-8-29(26)32)56-45(66)36(54-41(62)30(47)20-38(48)58)18-25-22-50-31-9-3-1-7-28(25)31/h1-4,7-10,12-15,22-23,30,33-37,50-51,57H,5-6,11,16-21,46-47H2,(H2,48,58)(H2,49,61)(H,52,65)(H,53,64)(H,54,62)(H,55,63)(H,56,66)(H,59,60)/t30-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: LEWOSKAMPUXEGW-BPAOWUMVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 910.00 | Molecular Weight (Monoisotopic): 909.4133 | AlogP: -0.90 | #Rotatable Bonds: 25 |
Polar Surface Area: 372.83 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.91 | CX Basic pKa: 10.27 | CX LogP: -3.75 | CX LogD: -3.85 |
Aromatic Rings: 5 | Heavy Atoms: 66 | QED Weighted: 0.03 | Np Likeness Score: 0.21 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):